| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
| Web: | mayocliniclabs.com |
|---|---|
| Email: | mcl@mayo.edu |
| Telephone: | 800-533-1710 |
| International: | +1 855-379-3115 |
| Values are valid only on day of printing | |
"People seem to be decreasing travel. More folks are wearing masks. They're following that hand, space, and vaccinate paradigm," says Dr. Gregory Poland, an infectious diseases expert and head of Mayo Clinic's Vaccine Research Group. "And it's working."
"A conscious effort should be made to make meaningful social connection with others," says Jon Ebbert, M.D., a Mayo Clinic internal medicine physician and senior author of the study. "During times of social strain and stress, it is important to not only be helpful to one another, but also be present."
"You get infected by a population of viruses," says Richard Kennedy, Ph.D., an immunologist and co-director of Mayo Clinic's Vaccine Research Group. "Each individual virus could be different from the others because mutations happen at random locations."
"I think that all of the creative solutions and accelerations in health care transformation will be what we'll carry with us," says Dr. Gray. "Because those will still be a day-to-day part of how we're taking care of patients and how we're performing our research and education duties."
The Food and Drug Administration has granted emergency use authorization for a new COVID-19 vaccine developed by Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson. The announcement means the U.S. now has three vaccines that effectively prevent severe COVID-19.
“Our findings will be crucial in treating and caring for COVID-19 survivors, as well as to try to prevent lingering complications in newly infected people,” says Konstantinos Lazaridis, M.D., the Everett J. and Jane M. Hauck associate director of Mayo Clinic Center for Individualized Medicine.
Fatigue and what's being called "brain fog" are turning out to be some of the most common issues for long-hauler patients recovering from COVID-19. The National Institutes of Health calls these and other symptoms, which can last for several months, post-acute sequelae of SARS-CoV-2, or PASC.
